Results 1-20 of 89 for drugs speaker:Pearse Doherty

Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)

Pearse Doherty: The Tánaiste talks about frustration. I mentioned that there must always be balance and consideration. The approval of a new drug is supposed to take 180 days. The Tánaiste talked about people with rare diseases and cancer patients. We are at the bottom of the list in Europe for accessing these drugs. All through the term of this Government that has been the situation. Irish...

Seanad: Substance Abuse: Motion (19 Dec 2007)

Pearse Doherty: ...éirigh leis deis a thabhairt do na páirtithe uilig tacaíocht a thabhairt don rún. Tugann mo pháirtí lán-tacaíocht don rún agus molaim é don tSeanad. The number of deaths as a result of drugs overdoses has increased markedly since 2001. According to figures provided by the Taoiseach to my colleague, Deputy Aengus Ó Snodaigh, such deaths increased by 32% between 2004 and 2005...

Seanad: Serious Crime: Motion (17 Oct 2007)

Pearse Doherty: ...of the Garda. A robust process of civilianisation would allow for more effective and focused use of existing resources, including a doubling of resources allocated to the national and local drug units. There can be no doubt that increased gun crime here is directly linked to the increased prevalence of drugs in our communities. A cache of guns and ammunition accompanies every major...

Seanad: Witness Protection Programme Bill 2007: Second Stage (31 Oct 2007)

Pearse Doherty: ...want to be protected from criminals through effective on-the-ground policing and not through being hidden away from family and friends with a false identity. If society is to seriously tackle drugs and gun crime, it is essential the gardaí work in genuine partnership with communities using the resources available in the most effective manner. This means the civilianisation of...

Seanad: National Drugs Strategy: Motion (18 Jun 2008)

Pearse Doherty: I am pleased to have an opportunity to speak on the important issue of the national drugs strategy. I do not support the motion but I will support the amendment tabled by the Fine Gael Party because it best reflects the current crisis we are in. Chronic underfunding has been a feature of this area. It is one thing to have a strategy but one needs to look at the reality to date with the...

Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)

Pearse Doherty: ...a dhéanamh. Caithfidh athrú teacht air seo. Tá staidéar déanta fá dtaobh de agus tá muid ar chúl san Eoraip ina thaobh. The IPHA is holding its annual conference today and it has highlighted the length of time it is taking the health service to approve the availability of new drugs. This has the potential to make real life-changing differences to...

Written Answers — Department of Health: Medicinal Products Licensing (18 Sep 2012)

Pearse Doherty: To ask the Minister for Health if he has any concerns with respect to the drug rasilez aliskiren, if he is aware of other countries that have outlawed the drug; and if he will make a statement on the matter. [37685/12]

Written Answers — Department of Health: Drugs Payment Scheme Coverage (16 Oct 2014)

Pearse Doherty: 162. To ask the Minister for Health if a decision has been made by the Health Service Executive to include the drug Eculizumab in the community drugs scheme; and if he will make a statement on the matter. [39583/14]

Written Answers — Department of Health: Medicinal Products Availability (10 Feb 2015)

Pearse Doherty: 389. To ask the Minister for Health if a decision has been made by the Health Service Executive to include the drug Daxas in the community drugs scheme; and if he will make a statement on the matter. [5456/15]

Written Answers — Department of Health: Medicinal Products Supply (13 Oct 2015)

Pearse Doherty: 285. To ask the Minister for Health his plans for the drug Sapropterin, also known as Kuvan, to be added to the drug reimbursement programme. [35478/15]

Written Answers — Department of Health: Drugs Payment Scheme Coverage (2 Dec 2015)

Pearse Doherty: 137. To ask the Minister for Health the status of the application to include the drug Kuvan Sapropterin in the drug re-imbursement programme; and if he will make a statement on the matter. [43172/15]

Written Answers — Department of Health: Drugs Payment Scheme Coverage (17 May 2016)

Pearse Doherty: 760. To ask the Minister for Health when he will make a decision on an application to include the drug kuvan sapropterin in the drug reimbursement programme; and if he will make a statement on the matter. [10033/16]

Written Answers — Department of Health: Drugs Payment Scheme Coverage (26 Oct 2016)

Pearse Doherty: 132. To ask the Minister for Health when he will make a decision on an application to include the drug Kuvan sapropterin in the drug reimbursement programme; and if he will make a statement on the matter. [32254/16]

Written Answers — Department of Health: Drugs Payment Scheme Coverage (16 Oct 2018)

Pearse Doherty: 347. To ask the Minister for Health if the drug refund scheme will be extended to include drugs prescribed outside the State for persons accessing IVF treatment abroad; and if he will make a statement on the matter. [41746/18]

Written Answers — Department of Health: Medicinal Products Supply (14 May 2013)

Pearse Doherty: 659. To ask the Minister for Health if he will consider including pirfenidone on the drug payment scheme for sufferers of lung fibrosis; if he will confirm that is the only drug available to treat patients with idiopathic lung fibrosis; and when the Health Service Executive will conclude its negotiations with the manufacturer [22656/13]

Written Answers — Department of Health: Medicinal Products (12 Mar 2013)

Pearse Doherty: To ask the Minister for Health further to a report in a Sunday newspaper which suggested that generic drugs and medicines here cost as much as 24 times more than the same medicines in Britain, the research he had undertaken in this area and the steps he will take to ensure that drugs and medicines are acquired at reasonable prices here. [12633/13]

Written Answers — Medicinal Products: Medicinal Products (14 Jun 2012)

Pearse Doherty: Question 158: To ask the Minister for Health the legislation, regulations and guidelines currently in place pertaining to the use of psychiatric, psycho stimulant psychotropic drugs such as ritalin and prozac on minors; if he is satisfied that these regulations ensure that only drugs which have been adequately and independently tested in clinical trials are prescribed; and if he will make a...

Written Answers — Department of Health: Medicinal Products (12 Mar 2013)

Pearse Doherty: To ask the Minister for Health further to a report in a Sunday newspaper which suggested that generic drugs and medicines here cost as much as 24 times more than the same medicines in Britain, the research undertaken by his Department or by the Competition Authority in this area and the steps he will take to ensure that drugs and medicines are sold at reasonable prices here. [12634/13]

Written Answers — Department of Health: Medicinal Products (14 Feb 2013)

Pearse Doherty: To ask the Minister for Health if he will advise the annual State spend on high tech drugs in each of the years 2009, 2010, 2011 and 2012; if he will list the medications involved; if he will advise the savings he has negotiated and secured across each of the relevant expenditures; the way he will deliver the €10m savings in the high tech drugs bill as outlined in the Health Service...

Joint Oireachtas Committee on Justice, Defence and Equality: Recent Controversies Concerning An Garda Síochána (30 Mar 2017)

Pearse Doherty: I thank Senator Conway. Deputies are being called to the Dáil for an imminent vote. As I have been saying for a number of years, the amount of controlled drugs that An Garda Síochána is holding is bizarre. I know the Tánaiste and Minister for Justice and Equality, Deputy Fitzgerald, has asked the Commissioner for a report on this. The most recent figures I have are...